Ahead of the 2015 AACR Annual Meeting we discuss how insulin resistance relates to current cancer therapies.
Michael Pollak, MD
Advertisement
Articles by Michael Pollak, MD
Advertisement
Latest Updated Articles
AACR: Insulin Signaling and Cancer Development, ProgressionPublished: April 17th 2015 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Novel Blood-Based Prostate Cancer Test for Elevated PSA Levels
2
FDA Approves Updated Cosibelimab Label in Cutaneous Squamous Cell Carcinoma
3
Zanidatamab Shows Meaningful Benefit in HER2+ Biliary Tract Cancer
4
FDA Grants Fast Track Designation to Novel FLT3/CD3 Bispecific in R/R AML
5
